Prevest Denpro Ltd

Prevest Denpro Ltd, a micro-cap player in the Healthcare Services sector, has seen its quality rating upgraded from average to good, reflecting improvements in key financial metrics such as return on capital employed and sales growth. However, despite this positive shift, the company’s overall market performance and fundamental indicators present a mixed picture, warranting a cautious approach from investors.

Prevest Denpro Ltd., one of the world's leading dental materials manufacturers, reported a robust fourth quarter for FY26, with consolidated net profit surging 23.31% quarter-on-quarter to ₹5.82 crores and 13.23% year-on-year. However, the stock has struggled in the aftermath, trading at ₹400.00 as of May 29, down 35.70% from its 52-week high of ₹622.05, as investors grapple with premium valuations and a mildly bearish technical outlook. The ₹480.12 crore market capitalisation company faces a critical juncture as strong operational performance clashes with stretched multiples.

Prevest Denpro Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Prevest Denpro Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Prevest Denpro Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Prevest Denpro Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Prevest Denpro Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock has posted a strong weekly gain of 6.2%, outperforming the Sensex’s 0.7% rise, signalling a nuanced market sentiment that warrants close analysis.

Prevest Denpro Ltd is rated Sell by MarketsMOJO. This rating was last updated on 06 Nov 2025, reflecting a reassessment of the stock’s outlook. However, the analysis below is based on the company’s current fundamentals, returns, and financial metrics as of 12 April 2026, providing investors with the latest perspective on the stock’s position.

Prevest Denpro Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

For the third consecutive session, Prevest Denpro Ltd has declined, culminating in a fresh 52-week low of Rs 344.3 on 30 Mar 2026. This marks a 6.23% drop over the last three days, underperforming its sector and the broader market amid a challenging environment for the healthcare services stock.

For the fifth consecutive session, Prevest Denpro Ltd has closed lower, hitting a fresh 52-week low of Rs 354.4 on 27 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance is notably sharper than its sector peers.

While the broader market surged with the Sensex climbing 1.63% to 75,273.45, Prevest Denpro Ltd has diverged sharply, hitting a fresh 52-week low of Rs 355.1 on 25 Mar 2026 amid persistent selling pressure and sector outperformance.

A sharp decline in Prevest Denpro Ltd has pushed the stock to a fresh 52-week low of Rs 362 on 24 Mar 2026, marking a 17.83% drop over the past year and signalling intensified selling pressure despite some positive financial indicators.

Prevest Denpro Ltd’s stock price declined to a fresh 52-week low of Rs.365.05 on 23 March 2026, reflecting ongoing pressures within the healthcare services sector and broader market weakness. The stock’s fall aligns with a challenging market environment and subdued company performance metrics.

Prevest Denpro Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 March 2026, providing investors with the latest insights into its performance and outlook.

Prevest Denpro Ltd, a micro-cap player in the Healthcare Services sector, has touched a new 52-week low of Rs.365.6 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting ongoing pressures on its valuation and performance metrics.

Prevest Denpro Ltd, a micro-cap player in the Healthcare Services sector, touched a new 52-week low of Rs.393 today, marking a significant decline in its share price amid broader market pressures and company-specific factors.

Prevest Denpro Ltd, a player in the Healthcare Services sector, has touched a new 52-week low of Rs.393 today, marking a significant decline in its stock price amid broader market volatility and sectoral pressures.